TESARO Announces Collaboration to Evaluate ZEJULA in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer Pharmaceutical Investing
Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational Progress Pharmaceutical Investing
Protalix BioTherapeutics Announces Additional Positive Results from Final Analysis of the Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis Biotech Investing
Axsome Therapeutics Initiates Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
Isodiol International Inc. Completes Acquisition of Farmtiva Inc. for 51% Ownership and Completes First Planting of Farm Bill Compliant Hemp in California Cannabis Investing News
Clovis Oncology Submits Application to EMA to Expand Use of Rubraca (rucaparib) to Include Maintenance Treatment for Women with Recurrent Ovarian Cancer Biotech Investing
Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018 Biotech Investing
CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting Biotech Investing
New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses Biotech Investing
